Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

ASA concerned over non-availability of sodium thiopental

The American Society of Anesthesiologists (ASA) and its members are extremely troubled to learn that the anesthetic drug, sodium thiopental (Pentothal®), will no longer be available to patients in the U.S. or any other country due to the unfortunate circumstances in Italy that led the sole manufacturer, Hospira, to cease production of the drug.

25 Jan 2011

FedEx launches Deep Frozen Shipping Solution for temperature-sensitive healthcare products

FedEx Corp. today announced the launch of FedEx Deep Frozen Shipping Solution, which offers an innovative end-to-end service for the shipping of temperature-sensitive healthcare products around the world.

24 Jan 2011

Myriant closes $60M strategic equity investment from PTT Chemical

Myriant Technologies, Inc., a privately-held, biotech developer and manufacturer of renewable bio-based chemicals, announced today the closing of a $60 million strategic equity investment from PTT Chemical Group, Thailand's largest petrochemical producer.

24 Jan 2011

BDSI refutes MonoSol's patent infringement claims relating to BEMA Buprenorphine

BioDelivery Sciences International, Inc. today responded to a process patent infringement lawsuit filed and recently served against the Company and certain co-defendants by MonoSol Rx, LLC. The purpose in responding at this time is for BDSI to strongly refute MonoSol's claims and to assure BDSI stockholders that the Company remains focused on vigorously progressing its pipeline and not allowing this claim to present a distraction.

24 Jan 2011

Environmental contaminant levels in mother's body decrease during breast-feeding: Study

The levels of environmental contaminants in a mother's body decrease during breast-feeding. After a year of lactation, the levels of a number of environmental contaminants in breast milk drop by 15 - 94 per cent, according to a recent study from the Norwegian Institute of Public Health. There has been little study into this topic previously.

24 Jan 2011

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

During an investor meeting held today in New York, NY, Watson Pharmaceuticals, Inc. provided an update on its Global businesses, including a detailed overview of its commercial operations and pipeline developments within its Global Generics and Global Brands businesses, and an update of achievements within its Global Operations. In conjunction with the meeting, the Company provided its preliminary 2011 financial and long term growth forecasts.

21 Jan 2011

NeoStem completes merger with Progenitor Cell Therapy

NeoStem, Inc. and Progenitor Cell Therapy LLC announced today the closing of their previously announced merger transaction.

21 Jan 2011

Viewpoints: Endorsing - and repudiating - health law repeal; Gov. Brewer on Ariz. Medicaid; Medical devices 'red tape'

The reason the GOP never got around to proposing a serious plan to expand coverage and control costs is because doing that is excruciatingly hard and politically dangerous. Look how long Democrats struggled to craft a measure and what happened to them after they passed it.

21 Jan 2011

Alliqua completes transdermal pain patch initial study for treatment of PHN

Alliqua, an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, announced today the successful completion of its initial study for the transdermal pain patch project.

20 Jan 2011

Genzyme to expand Geel facility to support growth of Myozyme and Lumizyme for Pompe disease

Genzyme Corp. today announced that it will build an additional manufacturing plant in Geel, Belgium, to support the long-term growth of Myozyme® and Lumizyme® for Pompe disease.

20 Jan 2011

FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Lamivudine and Zidovudine Tablets, 30 mg/60 mg.

20 Jan 2011

Perrigo to acquire Paddock Labs for $540M in cash

Perrigo Company today announced that it has signed a definitive agreement to acquire substantially all of the assets of Paddock Laboratories, Inc., a privately-held, Minneapolis-based manufacturer and marketer of generic pharmaceutical products for approximately $540 million in cash. Perrigo expects to receive a significant tax benefit as a result of the acquisition of Paddock's assets. The net present value of this tax benefit is estimated to be $95 million.

20 Jan 2011

FDA grants Soligenix Orphan Drug Designation to RiVax for prevention of ricin intoxication

Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to RiVax™ for the prevention of ricin intoxication. RiVax™ is a proprietary vaccine that contains a recombinant subunit of the A chain of ricin toxin which induces ricin neutralizing antibodies in humans and animals.

20 Jan 2011

Meridian Bioscience first quarter net sales decrease 12% to $37.3 million

Net sales for the first quarter of fiscal 2011 were $37,263,000 as compared to $42,457,000 for the same period of the prior fiscal year, a decrease of 12%. Net earnings for the first quarter of fiscal 2011 were $6,025,000, or $0.15 per diluted share, both decreases of 32% from the first quarter of fiscal 2010. Diluted common shares outstanding for the first quarter of fiscal 2011 and 2010 were 41,294,000 and 41,185,000, respectively.

20 Jan 2011

FDA approves Spectranetics PMA for manufacturing site change for CVX-300 laser system

Spectranetics Corporation today announced that the Food and Drug Administration (FDA) has approved the Company's premarket approval application (PMA) supplement requesting a manufacturing site change for the CVX-300® laser system.

20 Jan 2011

American Lung Association releases 2010 State of Tobacco Control Report

The American Lung Association released its State of Tobacco Control 2010 report today, which tracks progress on key tobacco control policies at the federal and state level, assigning grades based on whether laws are adequately protecting citizens from the enormous burden caused by tobacco use.

20 Jan 2011

Waters signs land-purchase agreement with Royal Bank of Scotland for new MS Headquarters in UK

Waters Corporation today announced it signed a land-purchase agreement with The Royal Bank of Scotland for a new Mass Spectrometry Headquarters in Wilmslow, Cheshire, near Manchester, U.K.

20 Jan 2011

U.S. Physical Therapy launches Fit2WRK to provide solutions for prevention of injuries in workplace

U.S. Physical Therapy, a national operator of outpatient physical therapy clinics, announced that it has successfully launched a workers compensation and disability initiative called Fit2WRK. Fit2WRK provides an integrated solution for the management and prevention of injuries in the workplace.

20 Jan 2011

Bluechiip, STMicroelectronics enter partnership to manufacture unique MEMS-based tracking tags

STMicroelectronics, the leading supplier of MEMS devices for consumer and portable applications, and Bluechiip Limited, an innovative early-stage company that has developed a groundbreaking tracking solution, today announced that the two companies are to cooperate in the manufacturing of unique MEMS-based tracking tags, aimed at a range of different markets, but initially in healthcare, such as biobanks.

20 Jan 2011

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency and the Army Research Office to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens.

20 Jan 2011

Manufacturing News and Research

Further Reading

ASA concerned over non-availability of sodium thiopental

FedEx launches Deep Frozen Shipping Solution for temperature-sensitive healthcare products

Myriant closes $60M strategic equity investment from PTT Chemical

BDSI refutes MonoSol's patent infringement claims relating to BEMA Buprenorphine

Environmental contaminant levels in mother's body decrease during breast-feeding: Study

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

NeoStem completes merger with Progenitor Cell Therapy

Viewpoints: Endorsing - and repudiating - health law repeal; Gov. Brewer on Ariz. Medicaid; Medical devices 'red tape'

Alliqua completes transdermal pain patch initial study for treatment of PHN

Genzyme to expand Geel facility to support growth of Myozyme and Lumizyme for Pompe disease

FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA

Perrigo to acquire Paddock Labs for $540M in cash

FDA grants Soligenix Orphan Drug Designation to RiVax for prevention of ricin intoxication

Meridian Bioscience first quarter net sales decrease 12% to $37.3 million

FDA approves Spectranetics PMA for manufacturing site change for CVX-300 laser system

American Lung Association releases 2010 State of Tobacco Control Report

Waters signs land-purchase agreement with Royal Bank of Scotland for new MS Headquarters in UK

U.S. Physical Therapy launches Fit2WRK to provide solutions for prevention of injuries in workplace

Bluechiip, STMicroelectronics enter partnership to manufacture unique MEMS-based tracking tags

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy